Long-Term Clinical and Angiographic Outcomes of Treatment of Unprotected Left Main Coronary Artery Stenosis With Sirolimus-Eluting Stents

Sheiban, Imad; Meliga, Emanuele; Moretti, Claudio; Biondi‐Zoccai, Giuseppe; Rosano, Giuseppe; Sciuto, Filippo; Marra, Walter Grosso; Omedè, Pierluigi; Gerasimou, Argyrios; Trevi, Gian Paolo

doi:10.1016/j.amjcard.2007.03.041

Cited by 43 publications

(22 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A 3.0-mm stent oversized with a bigger balloon after deployment may lead to an unfavorable outcome. 31 Finally, the technical features adopted here may limit the generalization of our results. Our preference for intravascular ultrasound-guided stenting or a selective rather than a systematic 2-stent strategy for bifurcation lesions may be associated with favorable outcomes.…”

Section: Discussionmentioning

confidence: 99%

Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents

et al. 2009

View full text Add to dashboard Cite

Background-Limited information is available on long-term outcomes for patients with unprotected left main coronary artery disease who received drug-eluting stents (DES). Methods and Results-In the multicenter registry evaluating outcomes among patients with unprotected left main coronary artery stenosis undergoing stenting with either bare metal stents (BMS) or DES, 1217 consecutive patients were divided into 2 groups: 353 who received only BMS and 864 who received at least 1 DES. The 3-year outcomes were compared by use of the adjustment of inverse-probability-of-treatment-weighted method. Patients receiving DES were older and had a higher prevalence of diabetes mellitus, hypertension, hyperlipidemia, and multivessel disease. In the overall population, with the use of DES, the 3-year adjusted risk of death (8.0% versus 9.5%; hazard ratio, 0.

show abstract

Section: Discussionmentioning

confidence: 99%

Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Recent studies report encouraging long-term clinical outcome [1][2][3][4]. However, lesion location and stenting technique can influence the incidence of adverse events.…”

Section: Introductionmentioning

confidence: 99%

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

Meliga

García‐García

Valgimigli

et al. 2009

International Journal of Cardiology

View full text Add to dashboard Cite

“…Even recent guidelines [4] consider coronary artery bypass graft (CABG) the preferred revascularization strategy for ULM disease, especially when distal bifurcation is involved and in presence of diffuse multivessel coronary disease [5]. Nevertheless clinical profile and age in specific can dramatically increase the surgical risk [6] and so, notwithstanding the encouraging results obtained in elective patients with ULM coronary disease treated with percutaneous coronary intervention (PCI) and drug-eluting stents (DES) [7][8][9][10], results in older population with ULM disease (generally excluded by randomized trials) are unclear. In this study, we specifically evaluated the feasibility and the efficacy of percutaneous ULM coronary disease treatment in older population (more than 75 years old) in a group of patients referred to a centre without onsite cardiothoracic surgical support in the contest of acute coronary syndrome (ACS).…”

Section: Introductionmentioning

confidence: 99%

Unprotected Left-Main Coronary Angioplasty in the Elderly in a High Volume Catheterization Centre without On-Site Surgery Facilities: Immediate and Medium Term Outcome—The Old-Placet Registry

Gagnor

Tomassini

Cerrato

et al. 2015

Advances in Vascular Medicine

View full text Add to dashboard Cite

We aim to assess clinical feasibility and efficacy of unprotected left main (ULM) percutaneous coronary intervention (PCI) in patients older than 75 years over a 6-year period and with 2-year follow-up demonstrating that PCI is a feasible revascularization strategy even in absence of on-site cardiothoracic support. Nevertheless, the outcome of these high-risk patients is still hampered by a sensible in-hospital mortality rate. Older patients have a higher mortality at follow-up (10.0 versus 0.8%, P = 0.014), while younger patients have a low mortality after the acute phase (15.7 versus 8.4%, P = 0.15).

show abstract

Long-Term Clinical and Angiographic Outcomes of Treatment of Unprotected Left Main Coronary Artery Stenosis With Sirolimus-Eluting Stents

Cited by 43 publications

References 23 publications

Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents

Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

Unprotected Left-Main Coronary Angioplasty in the Elderly in a High Volume Catheterization Centre without On-Site Surgery Facilities: Immediate and Medium Term Outcome—The Old-Placet Registry

Contact Info

Product

Resources

About